On February 22, 2021 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally-active antibody therapeutics based on its Probody technology platform, reported that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in the following virtual healthcare conferences in March (Press release, CytomX Therapeutics, FEB 22, 2021, View Source [SID1234575370]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Virtual Health Care Conference
Date: Monday, March 1, 2021
Panel Discussion: 1:20-2:20 p.m. ET

Barclays Global Virtual Healthcare Conference
Date: Wednesday, March 10, 2021
Presentation Time: 4:45-5:10 p.m. ET

A live webcast of the Barclays Global Virtual Healthcare Conference presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. An archived replay will be available for 90 days following the event.